
    
      Along with depressive symptoms, subjective and objective cognitive impairments are frequently
      complained by the patients with major depressive disorder. Tianeptine acts on glutamate
      system and is known as a promising drug for improving cognitive impairment.

      The present study aims to confirm the superiority of tianeptine compared to escitalopram on
      effects that improves subjective and objective cognitive impairments after a 12-week
      treatment in patients suffering from major depressive disorder.
    
  